Everett Magann
Concepts (666)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy | 234 | 2025 | 2608 | 10.230 |
Why?
| | Pregnancy Complications | 43 | 2025 | 406 | 9.490 |
Why?
| | Amniotic Fluid | 33 | 2023 | 70 | 8.220 |
Why?
| | Pregnancy Outcome | 64 | 2024 | 231 | 7.600 |
Why?
| | Ultrasonography, Prenatal | 40 | 2023 | 151 | 7.320 |
Why?
| | Obstetrics | 20 | 2022 | 87 | 5.000 |
Why?
| | Premature Birth | 25 | 2023 | 149 | 4.980 |
Why?
| | Oligohydramnios | 25 | 2023 | 40 | 4.740 |
Why?
| | Cesarean Section | 42 | 2024 | 158 | 4.560 |
Why?
| | Delivery, Obstetric | 32 | 2024 | 109 | 4.300 |
Why?
| | Female | 253 | 2025 | 28782 | 4.070 |
Why?
| | Gestational Age | 48 | 2024 | 394 | 3.480 |
Why?
| | Prenatal Care | 12 | 2023 | 111 | 3.210 |
Why?
| | Telemedicine | 12 | 2023 | 512 | 3.090 |
Why?
| | Postpartum Hemorrhage | 12 | 2018 | 38 | 2.970 |
Why?
| | Humans | 259 | 2025 | 53230 | 2.950 |
Why?
| | Labor Stage, Third | 9 | 2018 | 19 | 2.950 |
Why?
| | Polyhydramnios | 13 | 2019 | 24 | 2.760 |
Why?
| | Infant, Newborn | 75 | 2024 | 2913 | 2.640 |
Why?
| | Fetal Membranes, Premature Rupture | 7 | 2023 | 22 | 2.540 |
Why?
| | Placenta | 8 | 2022 | 146 | 2.430 |
Why?
| | Adult | 138 | 2024 | 14534 | 2.420 |
Why?
| | Uterine Rupture | 5 | 2023 | 10 | 2.410 |
Why?
| | Pre-Eclampsia | 14 | 2024 | 47 | 2.400 |
Why?
| | Obstetric Labor Complications | 12 | 2020 | 25 | 2.370 |
Why?
| | Hypertension, Pregnancy-Induced | 6 | 2024 | 19 | 2.230 |
Why?
| | Fetal Diseases | 7 | 2022 | 54 | 2.180 |
Why?
| | Pregnancy, High-Risk | 10 | 2021 | 48 | 1.740 |
Why?
| | Diabetes, Gestational | 6 | 2024 | 52 | 1.690 |
Why?
| | Pregnancy Complications, Neoplastic | 3 | 2024 | 21 | 1.570 |
Why?
| | Military Personnel | 10 | 2013 | 173 | 1.550 |
Why?
| | Parturition | 8 | 2023 | 51 | 1.540 |
Why?
| | Birth Weight | 14 | 2020 | 119 | 1.540 |
Why?
| | Risk Factors | 36 | 2025 | 4017 | 1.480 |
Why?
| | Gynecology | 8 | 2022 | 52 | 1.450 |
Why?
| | Labor, Obstetric | 11 | 2023 | 38 | 1.440 |
Why?
| | Labor, Induced | 11 | 2020 | 16 | 1.390 |
Why?
| | Fetal Growth Retardation | 10 | 2016 | 35 | 1.330 |
Why?
| | Infant, Small for Gestational Age | 11 | 2024 | 35 | 1.330 |
Why?
| | Hypertension | 8 | 2024 | 554 | 1.320 |
Why?
| | Pregnancy Complications, Cardiovascular | 6 | 2024 | 31 | 1.300 |
Why?
| | Pregnancy, Abdominal | 3 | 2015 | 8 | 1.250 |
Why?
| | Uterine Diseases | 4 | 2020 | 10 | 1.200 |
Why?
| | Surgical Wound Dehiscence | 2 | 2021 | 18 | 1.200 |
Why?
| | Prospective Studies | 35 | 2024 | 2411 | 1.180 |
Why?
| | Vaginal Birth after Cesarean | 4 | 2023 | 7 | 1.160 |
Why?
| | Hemorrhage | 5 | 2023 | 226 | 1.150 |
Why?
| | Rural Health Services | 4 | 2016 | 179 | 1.130 |
Why?
| | Retrospective Studies | 46 | 2023 | 6819 | 1.110 |
Why?
| | Congenital Abnormalities | 5 | 2021 | 117 | 1.090 |
Why?
| | Peripartum Period | 4 | 2022 | 16 | 1.080 |
Why?
| | Abortion, Spontaneous | 2 | 2022 | 21 | 1.070 |
Why?
| | Pregnancy Complications, Infectious | 6 | 2021 | 83 | 1.050 |
Why?
| | Young Adult | 37 | 2024 | 4511 | 1.050 |
Why?
| | Pregnancy Trimester, Third | 11 | 2022 | 51 | 1.050 |
Why?
| | Postpartum Period | 10 | 2024 | 111 | 1.040 |
Why?
| | Twins | 7 | 2014 | 21 | 1.030 |
Why?
| | Obesity, Morbid | 2 | 2018 | 86 | 1.020 |
Why?
| | Obstetric Labor, Premature | 9 | 2016 | 26 | 1.000 |
Why?
| | Fetal Weight | 6 | 2014 | 10 | 1.000 |
Why?
| | Ultrasonography | 13 | 2023 | 426 | 0.940 |
Why?
| | Pregnancy Complications, Hematologic | 5 | 2021 | 15 | 0.930 |
Why?
| | Restless Legs Syndrome | 1 | 2025 | 13 | 0.900 |
Why?
| | Dye Dilution Technique | 5 | 2014 | 12 | 0.900 |
Why?
| | Dystocia | 8 | 2014 | 9 | 0.890 |
Why?
| | Ultrasonography, Doppler, Color | 4 | 2019 | 30 | 0.890 |
Why?
| | Referral and Consultation | 5 | 2015 | 299 | 0.880 |
Why?
| | Fetal Death | 5 | 2022 | 22 | 0.870 |
Why?
| | Fetus | 4 | 2020 | 191 | 0.850 |
Why?
| | Fetal Macrosomia | 9 | 2015 | 17 | 0.840 |
Why?
| | Body Mass Index | 12 | 2020 | 717 | 0.830 |
Why?
| | Uterine Prolapse | 1 | 2023 | 3 | 0.820 |
Why?
| | Morbidity | 4 | 2023 | 132 | 0.810 |
Why?
| | Uterus | 6 | 2023 | 81 | 0.810 |
Why?
| | Parity | 14 | 2020 | 46 | 0.810 |
Why?
| | Pelvic Girdle Pain | 1 | 2023 | 3 | 0.800 |
Why?
| | Antihypertensive Agents | 4 | 2024 | 130 | 0.790 |
Why?
| | Esophageal Neoplasms | 1 | 2024 | 113 | 0.790 |
Why?
| | Adrenal Gland Diseases | 1 | 2023 | 8 | 0.780 |
Why?
| | Surgical Wound Infection | 5 | 2017 | 118 | 0.780 |
Why?
| | Adrenal Insufficiency | 1 | 2023 | 19 | 0.770 |
Why?
| | Adenomyosis | 1 | 2022 | 1 | 0.760 |
Why?
| | Health Services Accessibility | 4 | 2021 | 477 | 0.750 |
Why?
| | Arkansas | 15 | 2025 | 2068 | 0.750 |
Why?
| | Domestic Violence | 3 | 2012 | 24 | 0.740 |
Why?
| | Maternal Death | 1 | 2022 | 7 | 0.740 |
Why?
| | Maternal Mortality | 5 | 2020 | 28 | 0.740 |
Why?
| | Rural Population | 4 | 2022 | 596 | 0.730 |
Why?
| | Cystitis | 1 | 2022 | 18 | 0.730 |
Why?
| | Hyperparathyroidism | 1 | 2022 | 30 | 0.710 |
Why?
| | Health Status Disparities | 2 | 2022 | 221 | 0.700 |
Why?
| | Postmenopause | 1 | 2022 | 85 | 0.700 |
Why?
| | Time Factors | 21 | 2024 | 2991 | 0.700 |
Why?
| | Privacy | 1 | 2021 | 20 | 0.690 |
Why?
| | Fetal Distress | 10 | 2020 | 11 | 0.690 |
Why?
| | Stomach Neoplasms | 1 | 2024 | 207 | 0.690 |
Why?
| | Communication Barriers | 1 | 2021 | 35 | 0.670 |
Why?
| | Spinal Cord Injuries | 1 | 2021 | 56 | 0.660 |
Why?
| | Practice Guidelines as Topic | 10 | 2020 | 502 | 0.660 |
Why?
| | Respiratory Distress Syndrome, Newborn | 4 | 2017 | 45 | 0.650 |
Why?
| | Torsion Abnormality | 1 | 2020 | 4 | 0.640 |
Why?
| | Education, Medical | 1 | 2022 | 111 | 0.640 |
Why?
| | Umbilical Cord | 1 | 2020 | 36 | 0.630 |
Why?
| | Adolescent | 32 | 2025 | 6907 | 0.630 |
Why?
| | Medically Underserved Area | 1 | 2020 | 46 | 0.630 |
Why?
| | Carcinoma, Signet Ring Cell | 1 | 2019 | 14 | 0.620 |
Why?
| | Placenta Diseases | 1 | 2019 | 13 | 0.620 |
Why?
| | Health Personnel | 2 | 2020 | 259 | 0.610 |
Why?
| | Disease Management | 1 | 2021 | 187 | 0.600 |
Why?
| | Adrenal Cortex Hormones | 2 | 2017 | 116 | 0.600 |
Why?
| | Urinary Bladder Calculi | 1 | 2018 | 4 | 0.590 |
Why?
| | Women's Health Services | 1 | 2019 | 14 | 0.590 |
Why?
| | Simplexvirus | 1 | 2019 | 17 | 0.590 |
Why?
| | Lymphatic Metastasis | 1 | 2019 | 211 | 0.590 |
Why?
| | Military Medicine | 1 | 2019 | 24 | 0.580 |
Why?
| | Herpes Simplex | 1 | 2019 | 25 | 0.580 |
Why?
| | Fetal Mortality | 3 | 2015 | 7 | 0.580 |
Why?
| | Obesity | 5 | 2020 | 1204 | 0.570 |
Why?
| | Uterine Inversion | 1 | 2018 | 1 | 0.570 |
Why?
| | Stillbirth | 4 | 2022 | 29 | 0.570 |
Why?
| | Cervical Ripening | 5 | 2016 | 6 | 0.570 |
Why?
| | Women, Working | 2 | 2012 | 4 | 0.550 |
Why?
| | Intensive Care Units, Neonatal | 3 | 2015 | 150 | 0.550 |
Why?
| | Internship and Residency | 2 | 2022 | 439 | 0.540 |
Why?
| | Patient Satisfaction | 3 | 2023 | 292 | 0.540 |
Why?
| | Diverticulum | 1 | 2017 | 21 | 0.530 |
Why?
| | Pregnancy, Twin | 2 | 2014 | 7 | 0.530 |
Why?
| | Mass Screening | 4 | 2012 | 362 | 0.520 |
Why?
| | Prenatal Diagnosis | 4 | 2022 | 94 | 0.520 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 145 | 0.510 |
Why?
| | Predictive Value of Tests | 17 | 2019 | 934 | 0.510 |
Why?
| | Stroke | 1 | 2022 | 520 | 0.510 |
Why?
| | Uterine Retroversion | 1 | 2016 | 2 | 0.510 |
Why?
| | Blood Loss, Surgical | 3 | 2012 | 66 | 0.490 |
Why?
| | Brachial Plexus Neuropathies | 2 | 2014 | 11 | 0.490 |
Why?
| | Pregnant Women | 4 | 2023 | 71 | 0.490 |
Why?
| | Prevalence | 8 | 2025 | 1034 | 0.490 |
Why?
| | Gastroschisis | 1 | 2016 | 38 | 0.490 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2016 | 4 | 0.490 |
Why?
| | Heart Rate, Fetal | 10 | 2016 | 56 | 0.490 |
Why?
| | Fish Products | 1 | 2016 | 3 | 0.490 |
Why?
| | Foodborne Diseases | 1 | 2016 | 14 | 0.490 |
Why?
| | Genetic Counseling | 1 | 2016 | 44 | 0.480 |
Why?
| | Adenocarcinoma | 1 | 2019 | 405 | 0.470 |
Why?
| | Mississippi | 8 | 2015 | 90 | 0.470 |
Why?
| | Genetic Testing | 1 | 2016 | 130 | 0.470 |
Why?
| | Incidence | 8 | 2025 | 1085 | 0.460 |
Why?
| | Death Certificates | 1 | 2015 | 17 | 0.460 |
Why?
| | Fetal Monitoring | 9 | 2013 | 35 | 0.460 |
Why?
| | Odds Ratio | 9 | 2016 | 567 | 0.460 |
Why?
| | Birth Certificates | 1 | 2015 | 26 | 0.460 |
Why?
| | Cervix Uteri | 3 | 2011 | 43 | 0.460 |
Why?
| | Tertiary Care Centers | 2 | 2015 | 86 | 0.460 |
Why?
| | Monitoring, Ambulatory | 1 | 2015 | 9 | 0.450 |
Why?
| | Catheterization | 3 | 2011 | 95 | 0.450 |
Why?
| | Magnetic Resonance Imaging | 4 | 2022 | 1583 | 0.450 |
Why?
| | Randomized Controlled Trials as Topic | 8 | 2021 | 630 | 0.440 |
Why?
| | Fetal Blood | 6 | 2010 | 79 | 0.440 |
Why?
| | Chorionic Gonadotropin | 1 | 2014 | 19 | 0.440 |
Why?
| | Pregnancy Trimester, First | 1 | 2014 | 23 | 0.430 |
Why?
| | Fractures, Bone | 3 | 2014 | 106 | 0.430 |
Why?
| | Automobile Driving | 1 | 2014 | 27 | 0.430 |
Why?
| | Tocolytic Agents | 5 | 2015 | 7 | 0.420 |
Why?
| | Lung Neoplasms | 2 | 2019 | 645 | 0.410 |
Why?
| | Blood Pressure | 5 | 2024 | 518 | 0.410 |
Why?
| | Sensitivity and Specificity | 12 | 2017 | 867 | 0.410 |
Why?
| | Posture | 2 | 2005 | 65 | 0.400 |
Why?
| | Truth Disclosure | 1 | 2013 | 15 | 0.400 |
Why?
| | Guideline Adherence | 3 | 2013 | 143 | 0.400 |
Why?
| | Algorithms | 4 | 2013 | 667 | 0.400 |
Why?
| | Spouse Abuse | 2 | 2012 | 10 | 0.390 |
Why?
| | Brain Injuries | 1 | 2014 | 160 | 0.380 |
Why?
| | Apgar Score | 11 | 2018 | 26 | 0.370 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2013 | 98 | 0.370 |
Why?
| | Ideal Body Weight | 1 | 2012 | 6 | 0.370 |
Why?
| | Body Weights and Measures | 1 | 2012 | 17 | 0.370 |
Why?
| | Magnesium Sulfate | 5 | 2016 | 9 | 0.370 |
Why?
| | Rupture, Spontaneous | 2 | 2022 | 19 | 0.360 |
Why?
| | Pilot Projects | 4 | 2022 | 726 | 0.360 |
Why?
| | Hydroxyprogesterones | 3 | 2021 | 5 | 0.360 |
Why?
| | Pregnancy Trimester, Second | 6 | 2020 | 21 | 0.360 |
Why?
| | Exercise | 2 | 2009 | 561 | 0.350 |
Why?
| | Gravidity | 3 | 2020 | 5 | 0.350 |
Why?
| | Reproducibility of Results | 5 | 2021 | 1219 | 0.350 |
Why?
| | Contraception | 1 | 2011 | 31 | 0.350 |
Why?
| | Nifedipine | 3 | 2024 | 24 | 0.350 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2011 | 1 | 0.340 |
Why?
| | Levonorgestrel | 1 | 2011 | 4 | 0.340 |
Why?
| | Case-Control Studies | 10 | 2023 | 1212 | 0.340 |
Why?
| | United States | 17 | 2023 | 5409 | 0.330 |
Why?
| | Blood Transfusion | 3 | 2021 | 127 | 0.330 |
Why?
| | Multivariate Analysis | 5 | 2014 | 598 | 0.330 |
Why?
| | Aerospace Medicine | 1 | 2010 | 3 | 0.330 |
Why?
| | Fluid Therapy | 2 | 2018 | 79 | 0.330 |
Why?
| | Infant Mortality | 7 | 2013 | 65 | 0.330 |
Why?
| | Tocolysis | 3 | 2015 | 3 | 0.320 |
Why?
| | Pregnancy, Multiple | 2 | 2007 | 18 | 0.320 |
Why?
| | Quality of Life | 3 | 2023 | 902 | 0.320 |
Why?
| | HELLP Syndrome | 4 | 2007 | 4 | 0.320 |
Why?
| | Diagnosis, Differential | 5 | 2019 | 1038 | 0.310 |
Why?
| | Triage | 4 | 2024 | 65 | 0.310 |
Why?
| | Treatment Outcome | 10 | 2024 | 5595 | 0.310 |
Why?
| | Battered Women | 1 | 2009 | 2 | 0.300 |
Why?
| | Clinical Competence | 3 | 2022 | 406 | 0.300 |
Why?
| | Regression Analysis | 3 | 2018 | 391 | 0.300 |
Why?
| | Acidosis | 3 | 2004 | 37 | 0.300 |
Why?
| | Cohort Studies | 11 | 2021 | 1557 | 0.300 |
Why?
| | Anemia, Sickle Cell | 2 | 2021 | 105 | 0.290 |
Why?
| | Bibliometrics | 1 | 2008 | 19 | 0.290 |
Why?
| | Middle Aged | 12 | 2022 | 13419 | 0.280 |
Why?
| | Publishing | 1 | 2008 | 41 | 0.280 |
Why?
| | Hospitalization | 4 | 2024 | 749 | 0.270 |
Why?
| | Chorioamnionitis | 4 | 2017 | 12 | 0.270 |
Why?
| | Homocysteine | 1 | 2008 | 127 | 0.270 |
Why?
| | Amnion | 3 | 2020 | 11 | 0.260 |
Why?
| | Hospitals | 2 | 2020 | 181 | 0.250 |
Why?
| | Risk Assessment | 9 | 2019 | 1368 | 0.250 |
Why?
| | Hypercalcemia | 1 | 2006 | 34 | 0.250 |
Why?
| | Remote Consultation | 2 | 2017 | 30 | 0.240 |
Why?
| | Birth Injuries | 4 | 2013 | 9 | 0.240 |
Why?
| | Umbilical Arteries | 5 | 2006 | 16 | 0.240 |
Why?
| | Oxytocin | 2 | 2005 | 18 | 0.240 |
Why?
| | Version, Fetal | 1 | 2005 | 1 | 0.240 |
Why?
| | Prognosis | 6 | 2018 | 2118 | 0.240 |
Why?
| | Lifting | 1 | 2005 | 2 | 0.240 |
Why?
| | Renal Insufficiency | 1 | 2006 | 108 | 0.240 |
Why?
| | Sex Education | 1 | 2025 | 18 | 0.230 |
Why?
| | Smoking | 4 | 2018 | 526 | 0.230 |
Why?
| | Noise | 1 | 2005 | 42 | 0.230 |
Why?
| | Puberty | 1 | 2025 | 28 | 0.230 |
Why?
| | Brachial Plexus | 3 | 2013 | 11 | 0.220 |
Why?
| | Cerebral Palsy | 2 | 2016 | 36 | 0.220 |
Why?
| | Placenta, Retained | 2 | 2016 | 3 | 0.220 |
Why?
| | Terbutaline | 2 | 2008 | 6 | 0.220 |
Why?
| | Labetalol | 1 | 2024 | 2 | 0.220 |
Why?
| | Chorion | 1 | 2004 | 1 | 0.210 |
Why?
| | Noise, Occupational | 1 | 2024 | 3 | 0.210 |
Why?
| | Coloring Agents | 1 | 2004 | 65 | 0.210 |
Why?
| | Health Education | 1 | 2025 | 159 | 0.210 |
Why?
| | Patient Care Team | 3 | 2021 | 278 | 0.200 |
Why?
| | Home Infusion Therapy | 1 | 2003 | 1 | 0.200 |
Why?
| | Urinary Tract Infections | 1 | 2023 | 56 | 0.200 |
Why?
| | Intensive Care, Neonatal | 1 | 2003 | 23 | 0.200 |
Why?
| | Blood Volume | 2 | 2018 | 62 | 0.200 |
Why?
| | Labor Stage, First | 4 | 2015 | 7 | 0.190 |
Why?
| | Confidence Intervals | 5 | 2016 | 158 | 0.190 |
Why?
| | Chorionic Villi | 2 | 2019 | 3 | 0.190 |
Why?
| | Caregivers | 1 | 2025 | 247 | 0.190 |
Why?
| | Abortion, Therapeutic | 1 | 2002 | 3 | 0.190 |
Why?
| | Logistic Models | 5 | 2011 | 947 | 0.190 |
Why?
| | Pubic Symphysis | 2 | 2015 | 3 | 0.190 |
Why?
| | Exudates and Transudates | 1 | 2002 | 5 | 0.190 |
Why?
| | Hospitals, Military | 2 | 2014 | 6 | 0.190 |
Why?
| | Intrauterine Devices | 2 | 2012 | 7 | 0.190 |
Why?
| | Sutures | 1 | 2002 | 36 | 0.180 |
Why?
| | Hospitals, Teaching | 2 | 2020 | 52 | 0.180 |
Why?
| | Exercise Therapy | 1 | 2023 | 105 | 0.180 |
Why?
| | Embryo Implantation | 1 | 2002 | 5 | 0.180 |
Why?
| | Chi-Square Distribution | 5 | 2012 | 291 | 0.180 |
Why?
| | Acute Disease | 2 | 2022 | 393 | 0.180 |
Why?
| | Uterine Hemorrhage | 1 | 2021 | 7 | 0.180 |
Why?
| | Medicaid | 4 | 2023 | 294 | 0.180 |
Why?
| | Hematoma | 1 | 2002 | 67 | 0.180 |
Why?
| | Infant, Newborn, Diseases | 2 | 2013 | 56 | 0.180 |
Why?
| | Male | 14 | 2022 | 27435 | 0.180 |
Why?
| | Drainage | 1 | 2002 | 92 | 0.180 |
Why?
| | Weight Gain | 3 | 2013 | 245 | 0.180 |
Why?
| | Emergency Service, Hospital | 2 | 2024 | 530 | 0.180 |
Why?
| | Licensure | 1 | 2021 | 13 | 0.170 |
Why?
| | Health Insurance Portability and Accountability Act | 1 | 2021 | 14 | 0.170 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 108 | 0.170 |
Why?
| | Mothers | 2 | 2017 | 269 | 0.170 |
Why?
| | Technology | 1 | 2021 | 21 | 0.170 |
Why?
| | Reproductive Health | 1 | 2021 | 9 | 0.170 |
Why?
| | Risk Adjustment | 1 | 2021 | 17 | 0.170 |
Why?
| | Maternal Age | 4 | 2015 | 42 | 0.170 |
Why?
| | Progestins | 2 | 2012 | 10 | 0.170 |
Why?
| | Fatal Outcome | 2 | 2019 | 193 | 0.170 |
Why?
| | Hysterectomy | 4 | 2021 | 91 | 0.170 |
Why?
| | Placenta Accreta | 1 | 2021 | 25 | 0.170 |
Why?
| | Child | 3 | 2025 | 7379 | 0.170 |
Why?
| | Antithrombin Proteins | 1 | 2020 | 1 | 0.170 |
Why?
| | Prolapse | 1 | 2020 | 7 | 0.170 |
Why?
| | Puerperal Disorders | 2 | 2015 | 22 | 0.160 |
Why?
| | Maternal Health Services | 1 | 2021 | 34 | 0.160 |
Why?
| | Sleep | 1 | 2002 | 195 | 0.160 |
Why?
| | Patient Care Planning | 1 | 2020 | 69 | 0.160 |
Why?
| | Quality Improvement | 1 | 2022 | 230 | 0.150 |
Why?
| | Surrogate Mothers | 1 | 2019 | 4 | 0.150 |
Why?
| | Chest Pain | 1 | 2019 | 55 | 0.150 |
Why?
| | Cross-Sectional Studies | 4 | 2017 | 1723 | 0.150 |
Why?
| | ROC Curve | 6 | 2016 | 246 | 0.150 |
Why?
| | Uterine Cervical Incompetence | 2 | 2011 | 3 | 0.150 |
Why?
| | Misoprostol | 3 | 2016 | 5 | 0.150 |
Why?
| | Oxytocics | 3 | 2016 | 6 | 0.150 |
Why?
| | Cerclage, Cervical | 2 | 2011 | 8 | 0.150 |
Why?
| | Dyspnea | 1 | 2019 | 78 | 0.150 |
Why?
| | Abdominal Pain | 1 | 2020 | 84 | 0.150 |
Why?
| | Honduras | 1 | 2019 | 2 | 0.150 |
Why?
| | Probability | 5 | 2008 | 171 | 0.150 |
Why?
| | Guatemala | 1 | 2019 | 5 | 0.150 |
Why?
| | Office Visits | 2 | 2013 | 45 | 0.150 |
Why?
| | Colombia | 1 | 2019 | 15 | 0.150 |
Why?
| | Acyclovir | 1 | 2019 | 9 | 0.150 |
Why?
| | Contraception Behavior | 1 | 2019 | 12 | 0.150 |
Why?
| | Tomography, X-Ray Computed | 3 | 2022 | 1180 | 0.150 |
Why?
| | Lithotripsy, Laser | 1 | 2018 | 6 | 0.150 |
Why?
| | Reference Values | 3 | 2019 | 311 | 0.150 |
Why?
| | Critical Illness | 1 | 2021 | 316 | 0.150 |
Why?
| | Internet | 1 | 2021 | 265 | 0.150 |
Why?
| | Mental Health Services | 1 | 2022 | 233 | 0.150 |
Why?
| | Australia | 3 | 2012 | 93 | 0.150 |
Why?
| | Term Birth | 2 | 2008 | 16 | 0.140 |
Why?
| | Obstetric Surgical Procedures | 1 | 2018 | 2 | 0.140 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 88 | 0.140 |
Why?
| | Wounds and Injuries | 3 | 2009 | 301 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2010 | 505 | 0.140 |
Why?
| | Vaginosis, Bacterial | 2 | 2011 | 8 | 0.140 |
Why?
| | Fetal Development | 2 | 2016 | 50 | 0.140 |
Why?
| | Fibronectins | 2 | 2011 | 36 | 0.140 |
Why?
| | Early Diagnosis | 1 | 2018 | 84 | 0.140 |
Why?
| | Age Factors | 3 | 2011 | 1136 | 0.140 |
Why?
| | Glucose Tolerance Test | 2 | 2010 | 61 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 625 | 0.140 |
Why?
| | Chronic Disease | 3 | 2024 | 580 | 0.140 |
Why?
| | Postoperative Complications | 4 | 2017 | 1099 | 0.130 |
Why?
| | Medical Records | 3 | 2014 | 85 | 0.130 |
Why?
| | Pyelonephritis | 1 | 2017 | 5 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2019 | 179 | 0.130 |
Why?
| | Aged | 3 | 2022 | 10429 | 0.130 |
Why?
| | Actinomyces | 1 | 2017 | 12 | 0.130 |
Why?
| | Actinomycosis | 1 | 2017 | 10 | 0.130 |
Why?
| | Indomethacin | 2 | 2015 | 36 | 0.130 |
Why?
| | Depression | 2 | 2017 | 621 | 0.130 |
Why?
| | Malpractice | 2 | 2008 | 16 | 0.130 |
Why?
| | Self-Injurious Behavior | 1 | 2017 | 34 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2025 | 523 | 0.130 |
Why?
| | Antioxidants | 1 | 2019 | 264 | 0.130 |
Why?
| | Telephone | 2 | 2017 | 70 | 0.130 |
Why?
| | Kidney | 1 | 2021 | 715 | 0.130 |
Why?
| | Reactive Oxygen Species | 1 | 2019 | 421 | 0.120 |
Why?
| | Symptom Assessment | 1 | 2016 | 32 | 0.120 |
Why?
| | Brain Waves | 1 | 2016 | 19 | 0.120 |
Why?
| | Patient Care Management | 1 | 2016 | 18 | 0.120 |
Why?
| | Systole | 1 | 2016 | 71 | 0.120 |
Why?
| | Puerperal Infection | 3 | 2005 | 4 | 0.120 |
Why?
| | Biophysical Phenomena | 2 | 2014 | 15 | 0.120 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2016 | 3 | 0.120 |
Why?
| | Colposcopy | 1 | 2016 | 17 | 0.120 |
Why?
| | Socioeconomic Factors | 2 | 2016 | 623 | 0.120 |
Why?
| | Suicidal Ideation | 1 | 2017 | 120 | 0.120 |
Why?
| | Pubic Symphysis Diastasis | 1 | 2015 | 2 | 0.120 |
Why?
| | Magnetoencephalography | 1 | 2016 | 89 | 0.120 |
Why?
| | Hospitals, Community | 2 | 2014 | 19 | 0.120 |
Why?
| | Humeral Fractures | 2 | 2013 | 8 | 0.120 |
Why?
| | Amniocentesis | 3 | 2004 | 7 | 0.120 |
Why?
| | Clavicle | 2 | 2013 | 7 | 0.120 |
Why?
| | Hospitals, University | 2 | 2014 | 75 | 0.120 |
Why?
| | Neuroprotective Agents | 1 | 2016 | 101 | 0.120 |
Why?
| | Urologic Diseases | 1 | 2015 | 9 | 0.120 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2011 | 169 | 0.110 |
Why?
| | Anticonvulsants | 1 | 2016 | 133 | 0.110 |
Why?
| | Endometritis | 3 | 2010 | 4 | 0.110 |
Why?
| | Drug Implants | 2 | 2011 | 35 | 0.110 |
Why?
| | Safety | 1 | 2015 | 78 | 0.110 |
Why?
| | Episiotomy | 1 | 2014 | 7 | 0.110 |
Why?
| | Sheep | 1 | 2014 | 99 | 0.110 |
Why?
| | Southwestern United States | 1 | 2014 | 17 | 0.110 |
Why?
| | Pregnancy in Diabetics | 3 | 2010 | 24 | 0.110 |
Why?
| | Louisiana | 1 | 2014 | 41 | 0.110 |
Why?
| | Southeastern United States | 1 | 2014 | 50 | 0.110 |
Why?
| | Clinical Protocols | 2 | 2012 | 109 | 0.110 |
Why?
| | Oxidative Stress | 1 | 2019 | 819 | 0.100 |
Why?
| | Physician-Patient Relations | 2 | 2013 | 146 | 0.100 |
Why?
| | Academic Medical Centers | 1 | 2014 | 153 | 0.100 |
Why?
| | Health Care Costs | 1 | 2015 | 178 | 0.100 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 274 | 0.100 |
Why?
| | Body Weight | 2 | 2013 | 524 | 0.100 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2010 | 18 | 0.100 |
Why?
| | Healthy People Programs | 1 | 2013 | 4 | 0.100 |
Why?
| | Counseling | 1 | 2014 | 141 | 0.100 |
Why?
| | Brain Diseases | 2 | 2005 | 85 | 0.100 |
Why?
| | Follow-Up Studies | 5 | 2017 | 2318 | 0.100 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2016 | 301 | 0.100 |
Why?
| | Image Enhancement | 1 | 2013 | 49 | 0.100 |
Why?
| | Depression, Postpartum | 1 | 2013 | 47 | 0.100 |
Why?
| | Adnexa Uteri | 1 | 2012 | 1 | 0.100 |
Why?
| | Digestive System | 1 | 2012 | 12 | 0.100 |
Why?
| | Retroperitoneal Space | 1 | 2012 | 26 | 0.100 |
Why?
| | Abdominal Wall | 1 | 2012 | 13 | 0.100 |
Why?
| | Peritoneum | 1 | 2012 | 16 | 0.100 |
Why?
| | Linear Models | 4 | 2021 | 287 | 0.100 |
Why?
| | Trial of Labor | 4 | 2008 | 4 | 0.090 |
Why?
| | Government Agencies | 1 | 2012 | 15 | 0.090 |
Why?
| | Birth Rate | 1 | 2012 | 3 | 0.090 |
Why?
| | Mandatory Reporting | 1 | 2012 | 11 | 0.090 |
Why?
| | Local Government | 1 | 2012 | 23 | 0.090 |
Why?
| | Hematocrit | 1 | 2012 | 40 | 0.090 |
Why?
| | Return to Work | 1 | 2012 | 11 | 0.090 |
Why?
| | Hemoglobins | 1 | 2013 | 114 | 0.090 |
Why?
| | Attitude of Health Personnel | 3 | 2012 | 371 | 0.090 |
Why?
| | Reference Standards | 1 | 2012 | 52 | 0.090 |
Why?
| | Patient Care | 1 | 2012 | 59 | 0.090 |
Why?
| | Motor Activity | 1 | 2013 | 227 | 0.090 |
Why?
| | Administration, Oral | 3 | 2024 | 456 | 0.090 |
Why?
| | Desogestrel | 1 | 2011 | 2 | 0.090 |
Why?
| | Urination | 1 | 2011 | 21 | 0.090 |
Why?
| | Contraceptive Agents, Female | 1 | 2011 | 5 | 0.090 |
Why?
| | Osmolar Concentration | 1 | 2011 | 61 | 0.090 |
Why?
| | Reproductive History | 1 | 2011 | 4 | 0.090 |
Why?
| | Infant | 4 | 2023 | 3805 | 0.090 |
Why?
| | Emotions | 1 | 2013 | 177 | 0.090 |
Why?
| | Drug Eruptions | 1 | 2011 | 14 | 0.090 |
Why?
| | Personal Satisfaction | 1 | 2012 | 76 | 0.090 |
Why?
| | Traction | 1 | 2011 | 7 | 0.090 |
Why?
| | Guidelines as Topic | 1 | 2012 | 111 | 0.090 |
Why?
| | Surgical Sponges | 1 | 2011 | 6 | 0.090 |
Why?
| | Labor Stage, Second | 2 | 2008 | 3 | 0.090 |
Why?
| | Periodicals as Topic | 2 | 2010 | 63 | 0.090 |
Why?
| | Medical Errors | 1 | 2011 | 21 | 0.090 |
Why?
| | Deglutition | 1 | 2011 | 45 | 0.090 |
Why?
| | Fetal Proteins | 1 | 2011 | 4 | 0.090 |
Why?
| | Communication | 1 | 2013 | 263 | 0.090 |
Why?
| | 17-alpha-Hydroxyprogesterone | 1 | 2011 | 1 | 0.090 |
Why?
| | Weight-Bearing | 1 | 2011 | 45 | 0.090 |
Why?
| | Family Practice | 1 | 2012 | 97 | 0.090 |
Why?
| | Metronidazole | 1 | 2011 | 32 | 0.080 |
Why?
| | Receptor, IGF Type 2 | 1 | 2010 | 4 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2013 | 324 | 0.080 |
Why?
| | Hemodynamics | 1 | 2012 | 236 | 0.080 |
Why?
| | Appendicitis | 2 | 2009 | 65 | 0.080 |
Why?
| | RNA, Untranslated | 1 | 2010 | 15 | 0.080 |
Why?
| | Severity of Illness Index | 4 | 2010 | 1049 | 0.080 |
Why?
| | Foreign Bodies | 1 | 2011 | 66 | 0.080 |
Why?
| | Hypersensitivity | 1 | 2011 | 83 | 0.080 |
Why?
| | Qualitative Research | 1 | 2013 | 384 | 0.080 |
Why?
| | International Classification of Diseases | 1 | 2010 | 70 | 0.080 |
Why?
| | Aviation | 1 | 2010 | 5 | 0.080 |
Why?
| | Length of Stay | 3 | 2021 | 684 | 0.080 |
Why?
| | GTP-Binding Protein alpha Subunits, Gs | 1 | 2010 | 4 | 0.080 |
Why?
| | Monitoring, Physiologic | 1 | 2011 | 122 | 0.080 |
Why?
| | Program Evaluation | 2 | 2025 | 359 | 0.080 |
Why?
| | Pelvis | 2 | 2015 | 66 | 0.080 |
Why?
| | Anti-Bacterial Agents | 3 | 2023 | 830 | 0.080 |
Why?
| | Anti-Infective Agents | 1 | 2011 | 107 | 0.080 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2010 | 63 | 0.080 |
Why?
| | Cardiac Complexes, Premature | 1 | 2009 | 3 | 0.080 |
Why?
| | Clothing | 1 | 2009 | 5 | 0.080 |
Why?
| | Naval Medicine | 1 | 2009 | 4 | 0.080 |
Why?
| | Perinatal Care | 2 | 2020 | 28 | 0.080 |
Why?
| | Uterine Contraction | 2 | 2008 | 30 | 0.080 |
Why?
| | Exercise Tolerance | 1 | 2009 | 43 | 0.080 |
Why?
| | Education, Medical, Continuing | 1 | 2010 | 76 | 0.080 |
Why?
| | Social Perception | 1 | 2009 | 29 | 0.080 |
Why?
| | Physicians | 2 | 2012 | 242 | 0.080 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 2009 | 2 | 0.080 |
Why?
| | Marital Status | 1 | 2009 | 18 | 0.080 |
Why?
| | Physician's Role | 1 | 2009 | 49 | 0.070 |
Why?
| | Medical History Taking | 1 | 2009 | 47 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2011 | 774 | 0.070 |
Why?
| | Pregnancy, Prolonged | 1 | 2008 | 2 | 0.070 |
Why?
| | Research Design | 2 | 2008 | 373 | 0.070 |
Why?
| | Patient Preference | 1 | 2009 | 44 | 0.070 |
Why?
| | Anthropometry | 2 | 2006 | 101 | 0.070 |
Why?
| | Attitude to Death | 1 | 2008 | 10 | 0.070 |
Why?
| | Evidence-Based Medicine | 2 | 2009 | 275 | 0.070 |
Why?
| | Surgical Procedures, Operative | 1 | 2009 | 66 | 0.070 |
Why?
| | Meta-Analysis as Topic | 1 | 2008 | 40 | 0.070 |
Why?
| | Emergency Treatment | 2 | 2008 | 29 | 0.070 |
Why?
| | Cardiotocography | 2 | 2005 | 6 | 0.070 |
Why?
| | Pregnancy, Ectopic | 1 | 2008 | 7 | 0.070 |
Why?
| | Asphyxia Neonatorum | 2 | 2010 | 11 | 0.070 |
Why?
| | Brain | 1 | 2016 | 1350 | 0.070 |
Why?
| | Fecal Incontinence | 1 | 2008 | 15 | 0.070 |
Why?
| | Societies, Medical | 2 | 2006 | 207 | 0.070 |
Why?
| | Lung | 1 | 2011 | 481 | 0.070 |
Why?
| | Constipation | 1 | 2008 | 37 | 0.070 |
Why?
| | Administration, Intravenous | 2 | 2020 | 73 | 0.070 |
Why?
| | Genomic Imprinting | 1 | 2007 | 11 | 0.070 |
Why?
| | Perinatal Mortality | 2 | 2020 | 4 | 0.070 |
Why?
| | Double-Blind Method | 3 | 2020 | 729 | 0.070 |
Why?
| | Nurse's Role | 1 | 2007 | 70 | 0.070 |
Why?
| | Breast Feeding | 1 | 2009 | 203 | 0.060 |
Why?
| | Forecasting | 1 | 2007 | 152 | 0.060 |
Why?
| | Body Size | 1 | 2007 | 32 | 0.060 |
Why?
| | Abdomen | 2 | 2006 | 71 | 0.060 |
Why?
| | Antacids | 1 | 2006 | 12 | 0.060 |
Why?
| | Workload | 1 | 2006 | 48 | 0.060 |
Why?
| | Ludwig's Angina | 1 | 2006 | 1 | 0.060 |
Why?
| | Stress, Psychological | 1 | 2008 | 282 | 0.060 |
Why?
| | Gastroesophageal Reflux | 1 | 2006 | 51 | 0.060 |
Why?
| | Creatinine | 1 | 2006 | 158 | 0.060 |
Why?
| | Breech Presentation | 1 | 2005 | 1 | 0.060 |
Why?
| | Mesothelioma | 1 | 2005 | 16 | 0.060 |
Why?
| | Comorbidity | 2 | 2023 | 638 | 0.060 |
Why?
| | Leptin | 1 | 2007 | 151 | 0.060 |
Why?
| | Uterine Neoplasms | 1 | 2005 | 57 | 0.060 |
Why?
| | Hemostasis, Surgical | 1 | 2005 | 11 | 0.060 |
Why?
| | Blood Gas Monitoring, Transcutaneous | 1 | 2005 | 7 | 0.060 |
Why?
| | Acid-Base Imbalance | 1 | 2005 | 2 | 0.060 |
Why?
| | Gene Frequency | 3 | 2010 | 97 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2009 | 346 | 0.060 |
Why?
| | Sepsis | 2 | 2009 | 240 | 0.060 |
Why?
| | Analgesics | 1 | 2006 | 104 | 0.060 |
Why?
| | Insulin | 1 | 2007 | 493 | 0.060 |
Why?
| | Patient Admission | 1 | 2005 | 81 | 0.060 |
Why?
| | Colonic Pseudo-Obstruction | 1 | 2004 | 2 | 0.060 |
Why?
| | Infant, Premature, Diseases | 2 | 2020 | 97 | 0.060 |
Why?
| | Pain, Postoperative | 1 | 2006 | 169 | 0.060 |
Why?
| | Antibiotic Prophylaxis | 1 | 2005 | 65 | 0.060 |
Why?
| | Hypoglycemia | 1 | 2005 | 62 | 0.060 |
Why?
| | Calcium | 1 | 2006 | 373 | 0.050 |
Why?
| | Proteins | 1 | 2007 | 351 | 0.050 |
Why?
| | Workplace | 1 | 2005 | 98 | 0.050 |
Why?
| | Statistics, Nonparametric | 3 | 2011 | 198 | 0.050 |
Why?
| | Pelvic Inflammatory Disease | 1 | 2004 | 8 | 0.050 |
Why?
| | Palliative Care | 1 | 2006 | 195 | 0.050 |
Why?
| | Thrombophlebitis | 1 | 2004 | 19 | 0.050 |
Why?
| | Arterial Pressure | 1 | 2024 | 44 | 0.050 |
Why?
| | Glycoproteins | 1 | 2004 | 121 | 0.050 |
Why?
| | Urogenital System | 1 | 2003 | 3 | 0.050 |
Why?
| | Pregnancy Trimesters | 2 | 2017 | 13 | 0.050 |
Why?
| | Drug Administration Schedule | 3 | 2011 | 370 | 0.050 |
Why?
| | Infusion Pumps | 1 | 2003 | 12 | 0.050 |
Why?
| | Cesarean Section, Repeat | 1 | 2003 | 5 | 0.050 |
Why?
| | Platelet Storage Pool Deficiency | 1 | 2003 | 1 | 0.050 |
Why?
| | Injections, Subcutaneous | 1 | 2003 | 55 | 0.050 |
Why?
| | Outpatients | 1 | 2004 | 131 | 0.050 |
Why?
| | Propionates | 1 | 2003 | 23 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2003 | 211 | 0.050 |
Why?
| | Emergency Medical Services | 1 | 2003 | 122 | 0.050 |
Why?
| | Hospital Costs | 1 | 2003 | 74 | 0.050 |
Why?
| | Multiple Organ Failure | 1 | 2003 | 51 | 0.050 |
Why?
| | Pregnancy Tests | 1 | 2002 | 2 | 0.050 |
Why?
| | Autopsy | 1 | 2022 | 46 | 0.050 |
Why?
| | Kidney Diseases | 1 | 2005 | 230 | 0.050 |
Why?
| | Chorionic Gonadotropin, beta Subunit, Human | 1 | 2002 | 4 | 0.050 |
Why?
| | Ovarian Diseases | 1 | 2002 | 2 | 0.050 |
Why?
| | Dinoprostone | 1 | 2002 | 43 | 0.050 |
Why?
| | Tissue Expansion | 1 | 2002 | 4 | 0.050 |
Why?
| | Heart Diseases | 1 | 2005 | 221 | 0.050 |
Why?
| | Health Promotion | 1 | 2005 | 278 | 0.050 |
Why?
| | Surgical Instruments | 1 | 2002 | 29 | 0.050 |
Why?
| | Contrast Media | 1 | 2003 | 178 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2021 | 28 | 0.040 |
Why?
| | Recurrence | 1 | 2003 | 694 | 0.040 |
Why?
| | Seizures | 1 | 2003 | 203 | 0.040 |
Why?
| | Emergencies | 1 | 2021 | 78 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 379 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 243 | 0.040 |
Why?
| | Reoperation | 1 | 2002 | 476 | 0.040 |
Why?
| | Embryo Transfer | 1 | 2019 | 24 | 0.040 |
Why?
| | Risk | 2 | 2013 | 306 | 0.040 |
Why?
| | Animals | 1 | 2014 | 13526 | 0.040 |
Why?
| | Mental Health | 1 | 2022 | 248 | 0.040 |
Why?
| | Placentation | 1 | 2019 | 14 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2020 | 489 | 0.040 |
Why?
| | Trophoblasts | 1 | 2019 | 32 | 0.040 |
Why?
| | Genotype | 2 | 2010 | 563 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2020 | 219 | 0.040 |
Why?
| | Treatment Failure | 2 | 2009 | 119 | 0.030 |
Why?
| | Georgia | 1 | 2017 | 42 | 0.030 |
Why?
| | Nicotine | 1 | 2018 | 180 | 0.030 |
Why?
| | APACHE | 1 | 2017 | 26 | 0.030 |
Why?
| | Betamethasone | 1 | 2016 | 3 | 0.030 |
Why?
| | Transportation | 1 | 2016 | 30 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2017 | 325 | 0.030 |
Why?
| | Cephalopelvic Disproportion | 1 | 2015 | 2 | 0.030 |
Why?
| | Obstetrical Forceps | 1 | 2015 | 5 | 0.030 |
Why?
| | Rupture | 1 | 2015 | 24 | 0.030 |
Why?
| | Psychometrics | 1 | 2017 | 244 | 0.030 |
Why?
| | Depressive Disorder, Major | 1 | 2017 | 149 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 214 | 0.030 |
Why?
| | Fracture Fixation | 1 | 2015 | 18 | 0.030 |
Why?
| | Urogenital Abnormalities | 1 | 2015 | 16 | 0.030 |
Why?
| | Suppositories | 1 | 2015 | 1 | 0.030 |
Why?
| | Administration, Rectal | 1 | 2015 | 10 | 0.030 |
Why?
| | Smoking Cessation | 1 | 2018 | 325 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2016 | 142 | 0.030 |
Why?
| | Radiography | 1 | 2015 | 476 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2016 | 236 | 0.030 |
Why?
| | Dexamethasone | 1 | 2016 | 429 | 0.030 |
Why?
| | South Carolina | 1 | 2014 | 21 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2013 | 10 | 0.030 |
Why?
| | New Zealand | 1 | 2012 | 21 | 0.020 |
Why?
| | Auscultation | 1 | 2012 | 10 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2012 | 182 | 0.020 |
Why?
| | Patient Safety | 1 | 2012 | 103 | 0.020 |
Why?
| | Canada | 1 | 2012 | 112 | 0.020 |
Why?
| | Self Report | 1 | 2013 | 225 | 0.020 |
Why?
| | Oximetry | 1 | 2012 | 65 | 0.020 |
Why?
| | Vagina | 1 | 2011 | 45 | 0.020 |
Why?
| | Area Under Curve | 1 | 2011 | 185 | 0.020 |
Why?
| | Models, Statistical | 1 | 2012 | 229 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 233 | 0.020 |
Why?
| | Chromogranins | 1 | 2010 | 6 | 0.020 |
Why?
| | Health Planning Guidelines | 1 | 2010 | 11 | 0.020 |
Why?
| | Inheritance Patterns | 1 | 2010 | 22 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2009 | 55 | 0.020 |
Why?
| | Medical Informatics | 1 | 2010 | 58 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 169 | 0.020 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2009 | 63 | 0.020 |
Why?
| | Administration, Intravaginal | 1 | 2008 | 3 | 0.020 |
Why?
| | Appendectomy | 1 | 2009 | 36 | 0.020 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 104 | 0.020 |
Why?
| | Virginia | 1 | 2008 | 19 | 0.020 |
Why?
| | Flatulence | 1 | 2008 | 3 | 0.020 |
Why?
| | Observer Variation | 1 | 2008 | 138 | 0.020 |
Why?
| | Shoulder | 1 | 2008 | 19 | 0.020 |
Why?
| | Rectum | 1 | 2008 | 55 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2007 | 41 | 0.020 |
Why?
| | Shoulder Fractures | 1 | 2007 | 6 | 0.020 |
Why?
| | Pelvic Floor | 1 | 2008 | 53 | 0.020 |
Why?
| | Pedigree | 1 | 2007 | 128 | 0.020 |
Why?
| | Haplotypes | 1 | 2007 | 96 | 0.020 |
Why?
| | Wisconsin | 1 | 2007 | 41 | 0.020 |
Why?
| | Data Collection | 1 | 2008 | 288 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2007 | 66 | 0.020 |
Why?
| | Obstetrics and Gynecology Department, Hospital | 1 | 2006 | 10 | 0.020 |
Why?
| | Adaptation, Psychological | 1 | 2008 | 233 | 0.020 |
Why?
| | Cytodiagnosis | 1 | 2005 | 42 | 0.010 |
Why?
| | Insurance, Liability | 1 | 2005 | 1 | 0.010 |
Why?
| | Compensation and Redress | 1 | 2005 | 2 | 0.010 |
Why?
| | Liability, Legal | 1 | 2005 | 11 | 0.010 |
Why?
| | Diagnosis-Related Groups | 1 | 2005 | 18 | 0.010 |
Why?
| | Mental Status Schedule | 1 | 2005 | 16 | 0.010 |
Why?
| | Diastole | 1 | 2005 | 66 | 0.010 |
Why?
| | Sex Characteristics | 1 | 2007 | 204 | 0.010 |
Why?
| | Washington | 1 | 2005 | 45 | 0.010 |
Why?
| | Registries | 1 | 2008 | 652 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2005 | 99 | 0.010 |
Why?
| | Pain Measurement | 1 | 2006 | 259 | 0.010 |
Why?
| | Cecostomy | 1 | 2004 | 4 | 0.010 |
Why?
| | Biophysics | 1 | 2004 | 12 | 0.010 |
Why?
| | Phenotype | 1 | 2007 | 803 | 0.010 |
Why?
| | Delivery Rooms | 1 | 2004 | 1 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2004 | 71 | 0.010 |
Why?
| | Maternal Welfare | 1 | 2004 | 8 | 0.010 |
Why?
| | Wound Infection | 1 | 2004 | 33 | 0.010 |
Why?
| | Decision Making | 1 | 2006 | 278 | 0.010 |
Why?
| | Suicide | 1 | 2005 | 89 | 0.010 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2004 | 29 | 0.010 |
Why?
| | Databases, Factual | 1 | 2007 | 742 | 0.010 |
Why?
| | Injury Severity Score | 1 | 2004 | 166 | 0.010 |
Why?
| | Resuscitation | 1 | 2003 | 72 | 0.010 |
Why?
| | Vancomycin | 1 | 2004 | 91 | 0.010 |
Why?
| | Eclampsia | 1 | 2003 | 1 | 0.010 |
Why?
| | Heparin | 1 | 2004 | 86 | 0.010 |
Why?
| | Liver | 1 | 2009 | 1150 | 0.010 |
Why?
| | Fever | 1 | 2004 | 112 | 0.010 |
Why?
| | Polyunsaturated Alkamides | 1 | 2003 | 4 | 0.010 |
Why?
| | Blood Gas Analysis | 1 | 2003 | 28 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 2004 | 132 | 0.010 |
Why?
| | Neutrophils | 1 | 2004 | 153 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 1367 | 0.010 |
Why?
| | Organ Size | 1 | 2003 | 226 | 0.010 |
Why?
| | Hypothyroidism | 1 | 2003 | 58 | 0.010 |
Why?
| | Tachycardia, Paroxysmal | 1 | 2002 | 6 | 0.010 |
Why?
| | Physical Examination | 1 | 2003 | 96 | 0.010 |
Why?
| | Gels | 1 | 2002 | 22 | 0.010 |
Why?
| | Laparotomy | 1 | 2002 | 37 | 0.010 |
Why?
| | Ovariectomy | 1 | 2002 | 114 | 0.010 |
Why?
| | Infant, Premature | 1 | 2004 | 331 | 0.010 |
Why?
| | Survival Analysis | 1 | 2002 | 659 | 0.010 |
Why?
| | Analgesics, Opioid | 1 | 2006 | 622 | 0.010 |
Why?
| | Asthma | 1 | 2003 | 319 | 0.010 |
Why?
|
|
Magann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|